BackAmryt Pharma Plc Overview

Amryt Pharma Plc Research & Development

Get informed when a big investor buys or sells

+ Follow

Quarterly R&D Expenses

$8.01M
27.23% YoY

As of Sep 30, 2022

Annual R&D Expenses (TTM)

$37.83M
12.62% YoY

Trailing 12 months ending Sep 30, 2022

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Amryt Pharma Plc (AMYT) FAQ

Stockcircle tracks research & development for Amryt Pharma Plc (AMYT), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Research & Development page is built for Amryt Pharma Plc's historical R&D spending trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use R&D spending as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main AMYT overview so you can move from this figure to the surrounding analysis quickly.